Syndicated Report

InCrowd Novel Coronavirus (COVID-19) Vaccine Development – Wave 3

February 8, 2021

Given the recent roll-out of the COVID-19 vaccine across the US, InCrowd conducted its third wave of research on perceptions and observations of infectious disease experts on the COVID-19 vaccine to gauge progress and perceptions. This report compares recent findings on efficacy, impact, and recommendations related to the COVID-19 vaccine with data from earlier in the year.*

* Please note, views in this survey reflect opinions only as reported by responding physicians.

Methodology:

  • Method:
    • 10-Minute MicroSurvey via InCrowd
  • Crowds:
    • Infectious disease doctors
  • Sample Size:
    • n = 101
      • Community Hospital, Academic Hospital, Office-based
  • Fielding Period:
    • January 21st – 22nd

InCrowd’s other COVID-19 Tracking Reports:

  • This field is for validation purposes and should be left unchanged.